How the US Pharmaceutical Contract Manufacturing Market is Evolving to Meet Demand
The US pharmaceutical contract manufacturing market is poised for remarkable growth, projected to reach USD 86.16 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.56%. This evolution is largely driven by the increasing demand for outsourcing, particularly within the biologics segment, which stands as the largest in the industry. The market's overall expansion is indicative...
0 Commentarios 0 Acciones 2 Views 0 Vista previa